Results 211 to 220 of about 353,583 (326)

A further face of the partial thromboplastin time APTT [PDF]

Journal of Thrombosis and Haemostasis, 2005
openaire   +3 more sources

Efanesoctocog Alfa Population Pharmacokinetics and Repeated Time‐To‐Event Analysis of Bleeds in Adults, Adolescents, and Children with Severe Hemophilia A

The Journal of Clinical Pharmacology, Volume 65, Issue 7, Page 860-872, July 2025.
Abstract Efanesoctocog alfa is a first‐in‐class high‐sustained factor VIII (HSF) replacement therapy for treatment of hemophilia A. This article presents population pharmacokinetics (PopPK) of efanesoctocog alfa and repeated time‐to‐event (RTTE) analysis of bleeding episodes in adults/adolescents (≥12 years of age) and children (<12 years).
Nancy Wong, Pratik Bhagunde, Joakim Nyberg, Suresh Katragadda, Marek Demissie, Annemieke Willemze, Craig Benson, Sreeraj Macha   +7 more
wiley   +1 more source

The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy. [PDF]

Biochem Med (Zagreb), 2021
Lapić I, Lončar Vrančić A, Coen Herak D, Rogić D.   +3 more
europepmc   +1 more source

P1659Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment [PDF]

, 2017
T. Moumneh, Y. Malledan, A. Calmes, E. Lacour, Prateek Roy   +4 more
openalex   +1 more source

Trends in resource utilization for new‐onset psychosis hospitalizations at children's hospitals

Journal of Hospital Medicine, Volume 20, Issue 7, Page 710-726, July 2025.
Abstract Background Children with new‐onset psychosis often require hospitalization for medical evaluation. Objectives The goal of this study was to assess variations in the management of children with new‐onset psychosis and characterize trends in resource utilization.
Ankita Gupta, Matt Hall, Benjamin Masserano, Averi Wilson, Katherine Johnson, Clifford Chen, Lasya Challa, Harita Katragadda, Vineeta Mittal   +8 more
wiley   +1 more source

Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Alemayehu E, Mohammed O, Belete MA, Mulatie Z, Debash H, Gedefie A, Weldehanna DG, Eshetu B, Shibabaw A, Tekele SG, Tilahun M, Ebrahim H.   +11 more
europepmc   +1 more source

A case of syphilis presenting with prolonged etiology‐unrevealed fever, accompanying activated partial thromboplastin time prolongation [PDF]

, 2018
Kazuhiro Yasuo
openalex   +1 more source

Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis Defects

Journal of Inherited Metabolic Disease, Volume 48, Issue 4, July 2025.
ABSTRACT Bile acid synthesis defects (BASDs) comprise a group of rare, often severe, metabolic disorders. Bile acid replacement therapy decreases toxic bile acid intermediates production and improves biochemical profiles, potentially delaying or stabilizing disease progression.
Yasmin Polak, Elles Marleen Kemper, Marc Engelen, Femke C. C. Klouwer, Kevin Berendse, Frédéric M. Vaz, Bart G. P. Koot, Eleonora (Noortje) L. Swart, Carla E. M. Hollak   +8 more
wiley   +1 more source

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study.

JMIR Med Inform, 2022
Boie SD, Engelhardt LJ, Coenen N, Giesa N, Rubarth K, Menk M, Balzer F.   +6 more
europepmc   +1 more source

Comparison of Russell Viper Venom–Based and Activated Partial Thromboplastin Time–Based Screening Assays for Resistance to Activated Protein C

, 2008
A. Zara Herskovits, Susan J. Lemire, Janina A. Longtine, David M. Dorfman   +3 more
openalex   +1 more source